The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Stimulant Treatment Patterns and Compliance in Children and Adults With Newly Treated Attention-Deficit/Hyperactivity Disorder
Open accessAbstract
OBJECTIVE: To identify newly treated cases of attention-deficit/hyperactivity disorder (ADHD), assess the presence of comorbid psychiatric conditions, identify pharmacological treatment patterns, and examine treatment compliance rates among children and adults with newly diagnosed and pharmacologically treated ADHD in a managed care population. METHODS: Children (aged 18 years or younger) and adults having newly treated ADHD were identified from medical and pharmacy claims in an administrative claims database from 6 health plans. Claims data for services or products provided between April 1, 1997, and September 30, 1999, was analyzed for the managed care population (604,538 children and 1,542,304 adults). Data on compliance, persistence, and pharmacological treatment patterns were collected for the 6 months prior to and the 18 months following each patient.s initial ADHD pharmacological treatment. A medication possession ratio (MPR) was calculated by dividing the number of days supplied in a prescription by the number of days until the next prescription was filled. Compliance was defined as an MPR >0.8 and persistence as an MPR >0.3. RESULTS: The prevalence of diagnosed ADHD in this population was 0.7% (11,962 [2%] of children and 2,636 [0.2%] of adults) and incidence of ADHD was 0.04% (735 [0.1%] of children and 162 [0.01%] of adults). The most common comorbid psychiatric condition for incident cases was depression (31.6% of children and 63% of adults). Few children and adults switched their initial ADHD treatment agent, 11% and 12%, respectively. Dose titration occurred in 67% of children and 54% of adults. On average, changes in treatment (switching, titrating) took place after 2 to 3 months of treatment. Although patients, on average, obtained more than 6 refills for a total 200 days supply, the majority of patients (84% of children and 88% of adults) were compliant for less than 2 months over the period they were refilling prescriptions. CONCLUSION: Although the majority of patients had dosage changes, these changes typically occurred after several months of treatment. Results suggest that, even though patients continued their ADHD medication for several months, they did not consistently take medication for more than 2 months. Given these treatment patterns, pharmacologic treatment in newly treated ADHD patients may be suboptimal and may impact outcomes, including the effectiveness and cost of treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“most maintain good adherence for fewer than two months (Perwien et al., 2004).”
From The influences of environmental enrichment, cognitive enhancement, and physical exercise on brain development: Can we alter the developmental trajectory of ADHD? (2011) · cites this paper as Perwien et al., 2004
In the citing paper
“estimated adherence rates in children with ADHD only range from 56% to 75%, 16 and more than 50% of patients with ADHD discontinue treatment regardless of its efficacy or symptom severity.17,18”
From Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment (2009) · cites this paper as [18]
In the citing paper
“Despite our high reported adherence rates, our physiological adherence findings are consistent with studies 1, 16,18,29 that have linked poor adherence to adverse outcomes.”
From Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment (2009) · cites this paper as [18]
In the citing paper
“However, unlike some previous studies, we found no associations between adherence and demographic factors such as age, sex, 17,22 family income, and single-parent status 1, 16,18,29,30”
From Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment (2009) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,635
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,627
DSM-III Disorders in Preadolescent Children
Anderson, J. C. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800130081010 · Cited by 1,466
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1792 · Cited by 950
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Empirically supported psychosocial treatments for attention deficit hyperactivity disorder
Pelham Jr, W. E., Wheeler, T., & Chronis, A. (1998) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp2702_6 · Cited by 755
Attention-deficit/hyperactivity disorder in adults: an overview
Faraone, S. V., Biederman, J., Spencer, T. J., Wilens, T., Seidman, L. J., Mick, E. O., & Doyle, A. E. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00889-1 · Cited by 703
Attention-Deficit, S. O., & Disorder, H. (2001) · Pediatrics · doi:10.1542/peds.108.4.1033 · Cited by 636
Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment, 2nd ed.
Barkley, R. A. (1998) · Cited by 632
Flagged first, then by citations
Research works printed but not linked: 2
- MTA Cooperative Group. A 14-month randomized clinical trial of treat- ment strategies for attention-deficit/hyperactivity disorder. Multimodal treat- ment study of children with ADHD. Arch Gen Psychiatry. 1999;56:1073-86.
- Shekin W, Asarnow RF, Hess E, Zaucha K, Wheeler N. A clinical and demographic profile of a sample of adults with ADHD, residual state. Comp Psychiatry. 1990;31(5):416-25.
Cited by
Sorted by citations
Items 101–136 of 136
Imagawa, H., Nagar, S. P., Montgomery, W. S., Nakamura, T., Sato, M., & Davis, K. L. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s150261 · Cited by 7
Jackson, R., & Wild, C. J. (2021) · Journal of Advances in Medicine and Medical Research · doi:10.9734/jammr/2021/v33i630857 · Cited by 7
Nayak, A. S., Nachane, H. B., Keshari, P. K., Parkar, S., Saurabh, K., & Arora, M. (2021) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_782_20 · Cited by 7
Improving Care Management in Attention-Deficit/Hyperactivity Disorder: An RCT
Guevara, J. P., Power, T. J., Bevans, K. B., Snitzer, L., Leavy, S., Stewart, D., Broomfield, C., Shah, S., Grundmeier, R. W., Michel, J. J., et al. (2021) · PEDIATRICS · doi:10.1542/peds.2020-031518 · Cited by 9
Palma, S. M. M., Natale, A. C. M. P., & Calil, H. M. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.08.044 · Cited by 7
Jackson, R., & Robertson, M. (2020) · JOURNAL OF MENTAL HEALTH AND CLINICAL PSYCHOLOGY · doi:10.29245/2578-2959/2019/1.1192 · Cited by 6
Meyers, J., Gajria, K., Candrilli, S., Fridman, M., & Sikirica, V. (2017) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2016-0039 · Cited by 5
Jackson, R., & Jordan, J. T. (2022) · Humanities and Social Sciences Communications · doi:10.1057/s41599-022-01333-y · Cited by 8
Brancati, G., Dominicis, F. D., Petrucci, A., Pallucchini, A., Carli, M., Medda, P., Schiavi, E., de Rossi, P., Vicari, S., & Perugi, G. (2023) · World Journal of Biological Psychiatry · doi:10.1080/15622975.2023.2168750 · Cited by 5
Palma, S. M. M., Natale, A. C. M. P., & Calil, H. M. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00135 · Cited by 15
Froehlich, T. E. (2017) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000513 · Cited by 5
Reichenberg, L. W., & Seligman, L. (2016) · Wiley eBooks · doi:10.1002/9781394259465.ch2 · Cited by 5
Elefante, C., & Perugi, G. (2025) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000570 · Cited by 4
Huang, K., Hsu, J.-W., Tsai, S., Bai, Y., Chen, T., & Chen, M. (2021) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2020.0136 · Cited by 4
Attention-Deficit/Hyperactivity Disorder
Leffa, D. T., & Rohde, L. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-76136-3_28 · Cited by 4
Affordances of mHealth technology and the structuring of clinic communication
Mikesell, L., Marti, F., Guzmán, J. R., McCreary, M., & Zima, B. T. (2018) · Journal of Applied Communication Research · doi:10.1080/00909882.2018.1465195 · Cited by 3
Comorbidity and Factors Affecting Treatment Non-Persistence in ADHD
Park, J., & Kim, B. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715587097 · Cited by 4
Sullivan, D., Payne, L., Boulton, K., Silove, N., Bellgrove, M. A., Sciberras, E., Coghill, D., Guastella, A. J., & Middeldorp, C. M. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-064920 · Cited by 3
Pharmacoepidemiology of Psychotropic Medications in Youth
Safer, D. J., & ZITO, J. M. (2012) · Wiley eBooks · doi:10.1002/9781119958338.ch2 · Cited by 3
Liu, J. W., Jasim, M., Song, J., Ha, S.-H., Kim, J.-S., Kim, D., Lee, H., Kim, B. S., & Jung, H.-T. (2025) · ACM Transactions on Computer-Human Interaction · doi:10.1145/3772068 · Cited by 2
Schein, J. R., Cloutier, M., Gauthier‐Loiselle, M., Catillon, M., Meng, Y., Libchaber, B., Jiang, F., & Childress, A. C. (2024) · Neurology and Therapy · doi:10.1007/s40120-024-00681-y · Cited by 2
Cognitive outcomes of the at-home brain balance program
Jackson, R., & Meng, Y. (2024) · Frontiers in Child and Adolescent Psychiatry · doi:10.3389/frcha.2024.1450695 · Cited by 1
Characterizing patterns of care using administrative claims data: ADHD treatment in children
Klein, G. R., Greenhouse, J. B., Stein, B. D., & Seltman, H. J. (2011) · Health Services and Outcomes Research Methodology · doi:10.1007/s10742-011-0076-4 · Cited by 1
Once-daily medications for the pharmacological management of ADHD in adults
Tcheremissine, O. V. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s4206 · Cited by 1
Medikamentengabe und Psychotherapie
SCHIMMELMANN, B. G. (2013) · Vandenhoeck & Ruprecht eBooks · doi:10.13109/9783666462641.117 · Cited by 1
Ninlanon, K., Phattanarudee, S., Sakulbumrungsil, R. C., & Tan‐Khum, T. (2015) · Journal of Mental Health of Thailand - วารสารสุขภาพจิต แห่งประเทศไทย · doi:10.14456/dmhjournal.2015.12 · Cited by 1
Reducing the Risk of Fractures - The Options Narrow for Cost-Effective Therapeutic Alternatives
Curtiss, F. R. (2004) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2004.10.2.168 · Cited by 1
Kook, S., Kim, J., Cheon, K.-A. A., Jhung, K., & Song, D. (2013) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.2013.24.3.157 · Cited by 2
Alliance and Mechanisms of Medication Adherence in Pediatric Psychiatric Practice
Nadai, D., & Stevens, A. (2013)
Curtiss, F. R. (2004) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2004.10.2.167
Raman, S. R. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/p978-dt55
Knipp, D. K. (2005) · UA Campus Repository (The University of Arizona)
Effects of Exercise Type on Core Symptoms of ADHD in Children：A Systematic ReviewPreprint
Li, L., Song, Y., Zhang, L., & Wu, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2954164/v1
Meggs, J. (2024) · Mental Health Review Journal · doi:10.1108/mhrj-01-2024-0004
Cabelguen, C., Challet‐Bouju, G., Thiabaud, E., Donnio, Y., Lefebvre, L., Hardouin, J.-B., & Grall‐Bronnec, M. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-111698
Liu, J., Kang, B., Deng, W., Hao, Z., Yang, C., & Zhang, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1819206
Metadata
- Authors
- Perwien, A. R., Hall, J., Swensen, A., & Swindle, R.
- Affiliations
- Eli Lilly (United States) (US)
- ORCID
- Swindle, Ralph
- Venue
- Journal of Managed Care Pharmacy
- Publisher
- Academy of Managed Care Pharmacy
- Published
- 2004-03
- Volume
- 10
- Issue
- 2
- Pages
- 122-129
- ISSN
- 1083-4087 (ISSN-L)
- 1944-706X
- PMC
- PMC10437731
- OpenAlex
- W2148237638
- Cited by
- 136
- References
- 30
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 6 · 2015: 9 · 2014: 11 · 2013: 10 · 2012: 13
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Managed Care Pharmacy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- attention deficit hyperactivity disorder, stimulant medication, medication adherence, treatment persistence, medication possession ratio, comorbid depression, dose titration, treatment switching, managed care, children and adults, prescription refills, psychiatric comorbidity, treatment patterns, pharmacy claims data, health plans
- MeSH terms
- Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Child, Preschool, Female, Humans, Longitudinal Studies, Male, Middle Aged, Patient Compliance, Retrospective Studies, United States, Drug Utilization Review
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
